A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer

NCT05105672 PHASE2 UNKNOWN

This is a single-arm, single-center phase II clinical study to explore the efficacy and safety of sintilimab combined with concurrent chemoradiation therapy as treatment in women with locally advanced cervical cancer.

Details

Lead sponsor	The Affiliated Hospital of Xuzhou Medical University
Phase	PHASE2
Status	UNKNOWN
Enrolment	20
Start date	Mon Mar 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Mar 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Uterine Cervical Neoplasms
• Sintilimab

Interventions

• Sintilimab
• Cisplatin
• External Beam Radiotherapy (EBRT)
• brachytherapy

Countries

China